The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2015

Filed:

Aug. 30, 2006
Applicants:

Guoying Zhou, Madison, IL (US);

Bernard Roizman, Chicago, IL (US);

Inventors:

Guoying Zhou, Madison, IL (US);

Bernard Roizman, Chicago, IL (US);

Assignee:

The University of Chicago, Chicago, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/01 (2006.01); C12N 15/869 (2006.01); A61K 39/245 (2006.01); A61K 49/00 (2006.01); A61K 47/48 (2006.01); A61K 38/20 (2006.01); C12Q 1/70 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48269 (2013.01); A61K 38/2086 (2013.01); A61K 47/48776 (2013.01); C12N 15/8695 (2013.01); C12N 2710/16643 (2013.01); C12N 2710/16645 (2013.01); C12N 2810/50 (2013.01); C12N 2810/852 (2013.01); C12Q 1/705 (2013.01);
Abstract

The invention relates to engineered Herpes simplex virus (HSV) particles that are targeted to one or more specific binding pair members, such as receptors. Also, recombinant vectors for producing such HSV particles are provided. By reducing the affinity of HSV for its natural receptor(s) and increasing the affinity for a selected receptor, the HSV particles of the invention are useful for targeting cells that express the selected receptor, which itself may be a product of genetic engineering. The ability to selectively target cells render the HSV particles. particularly useful in selectively diagnosing, treating, and imaging cells bearing the selected binding pair member, such as a receptor. The invention also provides for polynucleotide-based therapy to cells bearing the selected binding pair member such as a receptor.


Find Patent Forward Citations

Loading…